Literature DB >> 9458165

Disturbance of the cortical cholinergic innervation in Borna disease prior to encephalitis.

U Gies1, T Bilzer, L Stitz, J F Staiger.   

Abstract

Rats experimentally infected with the highly neurotropic Borna disease virus (BDV) display a wide variety of dysfunction such as learning deficiencies and behavioral abnormalities. Prior to the onset of encephalitis alterations of one of the major cortical neurotransmitters, acetylcholine, were monitored immunohistochemically by light and electron microscopy of its synthesizing enzyme choline acetyltransferase (ChAT). We found a progressing decrease in the number of ChAT-positive fibers, starting with discrete changes at day 6 post infection (p.i.) and ending with a nearly complete loss of cholinergic fibers, especially in the hippocampus and neocortex, suggesting a massive disturbance of the cholinergic innervation by day 15 p.i.. The fiber pathways (e.g., fimbria-fornix) connecting the basal forebrain with these target areas in the cortex displayed axon spheroids which are often linked to axonal transport dysfunction. No evidence for significant cellular destruction was seen in the brain, including the cells of origin of these axons in the basal forebrain. We conclude that the motor, mood, learning and memory disabilities in BDV-infected rats are likely to result, in part, from cortical cholinergic denervation. The present study gives new insights into the pathogenesis of neurological disease caused by a noncytopathogenic virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458165     DOI: 10.1111/j.1750-3639.1998.tb00133.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  10 in total

1.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Animal models of CNS viral disease: examples from borna disease virus models.

Authors:  Marylou V Solbrig
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-24

3.  Borna disease virus replication in organotypic hippocampal slice cultures from rats results in selective damage of dentate granule cells.

Authors:  Daniel Mayer; Heike Fischer; Urs Schneider; Bernd Heimrich; Martin Schwemmle
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 4.  Borna disease virus.

Authors:  Mady Hornig; Thomas Briese; W Ian Lipkin
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

5.  Pathogenesis of borna disease virus: granulocyte fractions of psychiatric patients harbor infectious virus in the absence of antiviral antibodies.

Authors:  O Planz; C Rentzsch; A Batra; T Winkler; M Büttner; H J Rziha; L Stitz
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Synaptic pathology in Borna disease virus persistent infection.

Authors:  D Gonzalez-Dunia; M Watanabe; S Syan; M Mallory; E Masliah; J C De La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  An infection-based model of neurodevelopmental damage.

Authors:  M Hornig; H Weissenböck; N Horscroft; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

8.  Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: a multidisciplinary analysis.

Authors:  David Dietz; Michael Vogel; Steven Rubin; Timothy Moran; Kathryn Carbone; Mikhail Pletnikov
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

Review 9.  Borna disease virus.

Authors:  I Jordan; W I Lipkin
Journal:  Rev Med Virol       Date:  2001 Jan-Feb       Impact factor: 6.989

10.  Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease.

Authors:  Chris J Carter
Journal:  J Alzheimers Dis Rep       Date:  2017-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.